Indeed, HCC tumors presenting molecular signatures of circadian dysfunction activate pro-carcinogenic pathways, including Wnt/β-catenin, Hedgehog, and PI3K/ATK/mTOR, and inhibit tumor suppressors such as ATM and p53 [36,47,48] (Figure 2). The gene discussed is TP53; the disease is neoplasm.